Liminatus Pharma Inc. (NASDAQ:LIMN) Sees Significant Decrease in Short Interest
by Sarita Garza · The Markets DailyLiminatus Pharma Inc. (NASDAQ:LIMN – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totaling 68,096 shares, a drop of 41.2% from the December 31st total of 115,893 shares. Based on an average trading volume of 165,133 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.3% of the company’s stock are short sold. Approximately 0.3% of the company’s stock are short sold. Based on an average trading volume of 165,133 shares, the days-to-cover ratio is currently 0.4 days.
Liminatus Pharma Trading Down 1.7%
Shares of NASDAQ:LIMN traded down $0.01 during trading on Friday, reaching $0.58. The company’s stock had a trading volume of 36,203 shares, compared to its average volume of 123,597. The stock has a market capitalization of $15.70 million and a PE ratio of -4.83. The firm’s 50 day simple moving average is $0.78 and its two-hundred day simple moving average is $2.13. Liminatus Pharma has a 12 month low of $0.58 and a 12 month high of $33.66.
Liminatus Pharma (NASDAQ:LIMN – Get Free Report) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.07) EPS for the quarter.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Liminatus Pharma in a report on Monday, December 29th. Wall Street Zen downgraded shares of Liminatus Pharma from a “hold” rating to a “strong sell” rating in a research report on Saturday, November 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.
Get Our Latest Stock Report on LIMN
About Liminatus Pharma
Liminatus Pharma, Inc is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.